Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

Lancet Articles Address Variety Of Global Health Issues
Health Community Should Welcome Human Rights Community"s Help With Reducing Maternal Deaths
generic viagra online
Biotech Leaders, Patient Advocates Highlight Cutting-Edge HIV/AIDS Therapies, Need For Next Generation Treatments
Leaders in biotechnology research and patient advocacy joined forces today at the 2009 BIO International Convention to discuss the latest breakthroughs in HIV/AIDS treatments. Following a keynote speech by Sir Elton John focused on the needs of the HIV/AIDS community, representatives of biotech companies previewed the next generation of treatments while patient advocates reiterated the need for new therapies, particularly for those who have developed resistance to existing medications. Researchers are developing new therapies that are more effective in treating HIV/AIDS, including an AIDS vaccine and new methods of delivery that hold the potential to increase patient compliance.
plastic surgery before after
News of the day
U.N. Program Has Little Effect In Reducing Deaths Among Children In Bangladesh, Study Finds
"The U.N. unveiled a multimillion dollar strategy a dozen years ago to save children worldwide, but a new [Lancet] study has found the program had surprisingly little effect in Bangladesh, one of the world"s poorest countries," the Associated Press reports. Since 1997, when the WHO and UNICEF launched the Integrated Management of Childhood Illness (IMCI) Program to help reduce the numbers of deaths in children under age 5 from diarrhea, pneumonia, measles and malnutrition, more than 100 countries have adopted the program, drawing upon "millions" in aid, according to the news service.
Nutrition

Wall Street Journal Examines Program To Spur Vaccine Development For Developing World Diseases

The Wall Street Journal examines a $1.5 billion program supported by Italy, the U.K., Canada, Russia, Norway and the Bill & Melinda Gates Foundation that hopes "to encourage pharmaceutical companies to develop vaccines for diseases common to poor countries," which is expected to be announced Friday "on the sidelines of a meeting of top finance officials from the Group of Eight major industrial powers." "Instead of buying existing drugs and giving them away, the donors will guarantee pharmaceutical companies a future market big enough to justify developing and manufacturing new vaccines needed in nations too impoverished to afford them on their own," the newspaper writes. The article explores why insufficient financial incentives tend to keep pharmaceutical companies from developing vaccines targeted to developing countries and how the program aims to overcome these barriers. The first focus of the program is a vaccine for pneumococcal disease, "which kills 1.6 million people in the world a year, the majority of them young children in the developing world," according to the Wall Street Journal, which adds, "The donors chose to go after pneumococcal disease rather than malaria, HIV/AIDS, tuberculosis or other infectious illnesses in part because the prospects appear good that new vaccines could hit the market as early as next year." In collaboration with UNICEF, the World Bank and the GAVI Alliance, the Wall Street Journal writes, the donors "will promise to purchase new pneumococcus vaccines that meet specified criteria for safety, durability and effectiveness." According to the Wall Street Journal, "The U.S. waxed enthusiastic about the approach after Italy and Britain began championing it four years ago, but never came up with a contribution" (Phillips, Wall Street Journal, 6/12). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009